Okava Pharmaceuticals Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Early Stage VC
- Investors
-
3
Okava Pharmaceuticals General Information
Description
Developer of pet medications intended to treat the needs of dogs and cats. The company focuses on treating chronic diseases in animals by repurposing validated human medicines to overcome the high developmental expenses associated with traditional drug development, enabling pharma companies to provide methods of treatment in a veterinary setting.
Contact Information
Website
www.okava.comCorporate Office
- 2047 Polk Street
- Unit A
- San Francisco, CA 94109
- United States
Corporate Office
- 2047 Polk Street
- Unit A
- San Francisco, CA 94109
- United States
Okava Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Jan-2019 | Completed | Pre-Clinical Trials |
Okava Pharmaceuticals Patents
Okava Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026143020-A1 | Dosage forms comprising mycophenolic acid and methods of their use | Pending | 24-Dec-2024 | ||
| CA-3111908-A1 | Methods and compositions for delivering mycophenolic acid active agents to non-human mammals | Inactive | 07-Sep-2018 | ||
| EP-3846798-A1 | Methods and compositions for delivering mycophenolic acid active agents to non-human mammals | Inactive | 07-Sep-2018 | ||
| WO-2020050863-A1 | Methods and compositions for delivering mycophenolic acid active agents to non-human mammals | Inactive | 07-Sep-2018 | ||
| AU-2018236225-A1 | Methods and compositions for delivering mycophenolic acid active agents to non-human mammals | Active | 13-Mar-2017 | A61K31/365 |
Okava Pharmaceuticals Signals
Okava Pharmaceuticals Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Venture Forward Capital | Venture Capital | Minority | ||
| Angel (individual) | Minority |
Okava Pharmaceuticals FAQs
-
When was Okava Pharmaceuticals founded?
Okava Pharmaceuticals was founded in 2015.
-
Where is Okava Pharmaceuticals headquartered?
Okava Pharmaceuticals is headquartered in San Francisco, CA.
-
What is the size of Okava Pharmaceuticals?
Okava Pharmaceuticals has 5 total employees.
-
What industry is Okava Pharmaceuticals in?
Okava Pharmaceuticals’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Okava Pharmaceuticals a private or public company?
Okava Pharmaceuticals is a Private company.
-
What is Okava Pharmaceuticals’s current revenue?
The current revenue for Okava Pharmaceuticals is .
-
Who are Okava Pharmaceuticals’s investors?
, Venture Forward Capital, and have invested in Okava Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process